The MEDXP Introduces Vissco Raised Toilet Seat Commode Riser, which is an elevated commode seat which substantially increases the height of any western commode. It makes sitting and getting up from the toilet seat easier for people suffering from injuries or joint pain. Benefits: No risk of slipping: Vissco Commode raiser consists of non-skid pads at the bottom of the seat. The elderly need not worry about slipping anymore. Safety first: Be it for someone elderly or for someone injured, Vissco Commode raiser is lightweight and can be installed in a simple and secure way. It reduces the risk of joint pain, knee pain and back pain. It ensures safety and provides relief from stiff joints.
There could be certain circumstances beyond our control where you could receive a damaged / defective product or a product that is not the same as per your original order. We will replace the product to your satisfaction at no extra cost .The return process of the product can be restricted depending on the nature and category of the product. Conditions for return:
Please notify us of receipt of a Damaged / Defective product within maximum 48 hours of delivery.
Products/Items should be UNUSED. Products should be returned in their original packaging along with the original price tags, labels and invoices.
It is advised that the return packets should be strongly and adequately packaged so that there is no further damage of goods in transit. REFUNDS: We will process the refund after receipt of the product by MEDSEXP or its business partner. Refund will be processed based on the mode of payment of the order
Orders paid by credit/ debit card will be refunded by credit back to the credit/ debit card within 7 working days and the refund will reflect in the next statement.
Orders paid by net banking accounts will be credited back to bank account.
For all other modes of payment, we will send a refund cheque. The cheque will be made in favor of the name as in the “billing name” provided at the time of placing the order

Reviews
There are no reviews yet.